Gigantic ovarian mucinosa carcinoma: clinical practice in modern oncology
- 20 October 2025
- journal article
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 5,p. 15-23
Abstract
This article describes a clinical case of the diagnosis and treatment of a giant mucinous ovarian carcinoma. The patient, a 67‑year-old woman, was diagnosed with a giant ovarian mass of uncertain or unknown nature, suspected of being ovarian cancer, after a comprehensive diagnostic examination. She underwent a combined cytoreductive surgery for ovarian cancer, including a laparotomic total hysterectomy with adnexectomy and omentectomy. The tumor weighed 28 kg. According to the results of surgical and pathomorphological staging, the diagnosis was established: mucinous carcinoma of the giant right ovary pT1a Pn0 Lv0 V0 (IA FIGO) The patient was discharged on day 5 with a satisfactory result, antitumor therapy is not indicated. No data on the progression of the disease was revealed during dynamic complex monitoring.Keywords
This publication has 12 references indexed in Scilit:
- Рак яичников, первичный рак брюшины и рак маточных трубMalignant tumours, 2024
- Giant mucinous cystadenocarcinoma of ovary in a young woman: a case report and review of literatureFrontiers in Oncology, 2024
- HRD-negative high-grade carcinoma of the ovary in BRCA2 pathogenic variant carrierSiberian journal of oncology, 2024
- Prognostic Factors for Ovarian Cancer (Review)Евразийский онкологический журнал, 2022
- Практические рекомендации по лекарственному лечению рака яичников, первичного рака брюшины и рака маточных трубMalignant tumours, 2021
- Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulationOncogenesis, 2020
- Current imaging techniques for staging and assessing the resectability of advanced ovarian cancerAkusherstvo i ginekologiia, 2019
- Mucinous Ovarian CarcinomaNew England Journal of Medicine, 2019
- Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancersCancer and Metastasis Reviews, 2019
- Progression-free survival in ovarian cancer patients in second remission with mucin-1 autologous dendritic cell therapy.Journal of Clinical Oncology, 2014